NCCN 1st Annual Forum:
Innovative Diagnostics & Therapeutics in Cancer Care™
Agenda
Thursday, September 4, 2008
Registration, Breakfast, and Exhibits
8:00 – 9:00 AM
Welcome
9:00 – 9:05 AM
Introduction/Overview – Keynote Speaker
9:10 – 9:30 AM
Maurie Markman, MD
The University of Texas M. D. Anderson Cancer Center
Breast Cancer
Evolving Role of Genomics in Breast Cancer Decision Making
9:35 – 9:55 AM
Harold J. Burstein, MD, PhD
Dana-Farber/Brigham and Women’s Cancer Center
Adjuvant Bisphosphonates?
10:00 – 10:20 AM
Robert W. Carlson, MD
Stanford Comprehensive Cancer Center
New Options in the Management of HER2-Positive Disease
10:25 – 10:45 AM
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Question/Answer and Discussion
10:50 – 11:20 AM
Break and Exhibits
11:20 – 11:35 AM
Non-Small Cell Lung Cancer
Tailoring NSCLC Therapy to Histologic Subtypes
11:35 – 11:55 AM
Mohammad Jahanzeb, MD
University of Tennessee Cancer Institute
Use of Predictive Biomarkers in NSCLC
12:00 – 12:20 PM
Gregory P. Kalemkerian, MD
University of Michigan Comprehensive Cancer Center
Making the Most of Imaging Studies: Assessing Response More Rapidly and Accurately
12:25 – 12:45 PM
Mark G. Kris, MD
Memorial Sloan-Kettering Cancer Center
Question/Answer and Discussion
12:50 – 1:20 PM
Lunch and Exhibits
1:20 – 2:10 PM
Colorectal Cancer
Risk Assessment in Early Stage Colorectal Cancer
2:10 – 2:35 PM
Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Anti-EGFR Therapy in Colorectal Cancer and the Role of Markers
2:40 – 3:00 PM
Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center
Beyond KRAS…
3:05 – 3:25 PM
Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Question/Answer and Discussion
3:30 – 4:00 PM
Closing Remarks
4:00 – 4:10 PM
View information on the NCCN 3rd Annual Congress: Hematologic Malignancies™.
Last update 06/30/2008. Subject to change.
|
Email
Print
Mark
